CL Educate Limited
CL Educate Limited (CLEDUCATE.NS) Stock Competitors & Peer Comparison
See (CLEDUCATE.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Education & Training Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CLEDUCATE.NS | ₹52.87 | +4.16% | 2.9B | -12.93 | -₹4.09 | N/A |
| NIITMTS.NS | ₹323.80 | +2.44% | 44.4B | 20.72 | ₹15.63 | +0.93% |
| NIITMTS.BO | ₹321.90 | +1.67% | 44.2B | 20.58 | ₹15.64 | +0.93% |
| CRIZAC.NS | ₹227.17 | +5.27% | 39.8B | 20.73 | ₹10.96 | +3.52% |
| CRIZAC.BO | ₹226.65 | +5.03% | 39.7B | 20.68 | ₹10.96 | +3.52% |
| VERANDA.NS | ₹154.19 | +4.36% | 14.8B | 15.98 | ₹9.65 | N/A |
| VERANDA.BO | ₹154.05 | +4.02% | 14.8B | 15.98 | ₹9.64 | N/A |
| NIITLTD.NS | ₹68.21 | +3.92% | 9.3B | 40.84 | ₹1.67 | +1.47% |
| NIITLTD.BO | ₹68.20 | +3.73% | 9.3B | 40.84 | ₹1.67 | +1.47% |
| GLOBAL.NS | ₹102.94 | +1.44% | 5.2B | 23.24 | ₹4.43 | +0.97% |
Stock Comparison
CLEDUCATE.NS vs NIITMTS.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, NIITMTS.NS has a market cap of 44.4B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while NIITMTS.NS trades at ₹323.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas NIITMTS.NS's P/E ratio is 20.72. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to NIITMTS.NS's ROE of +0.18%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to NIITMTS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check NIITMTS.NS's competition here
CLEDUCATE.NS vs NIITMTS.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, NIITMTS.BO has a market cap of 44.2B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while NIITMTS.BO trades at ₹321.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas NIITMTS.BO's P/E ratio is 20.58. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to NIITMTS.BO's ROE of +0.18%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to NIITMTS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check NIITMTS.BO's competition here
CLEDUCATE.NS vs CRIZAC.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, CRIZAC.NS has a market cap of 39.8B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while CRIZAC.NS trades at ₹227.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas CRIZAC.NS's P/E ratio is 20.73. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to CRIZAC.NS's ROE of +0.35%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to CRIZAC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check CRIZAC.NS's competition here
CLEDUCATE.NS vs CRIZAC.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, CRIZAC.BO has a market cap of 39.7B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while CRIZAC.BO trades at ₹226.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas CRIZAC.BO's P/E ratio is 20.68. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to CRIZAC.BO's ROE of +0.35%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to CRIZAC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check CRIZAC.BO's competition here
CLEDUCATE.NS vs VERANDA.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, VERANDA.NS has a market cap of 14.8B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while VERANDA.NS trades at ₹154.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas VERANDA.NS's P/E ratio is 15.98. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to VERANDA.NS's ROE of +0.25%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to VERANDA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check VERANDA.NS's competition here
CLEDUCATE.NS vs VERANDA.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, VERANDA.BO has a market cap of 14.8B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while VERANDA.BO trades at ₹154.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas VERANDA.BO's P/E ratio is 15.98. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to VERANDA.BO's ROE of +0.25%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to VERANDA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check VERANDA.BO's competition here
CLEDUCATE.NS vs NIITLTD.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, NIITLTD.NS has a market cap of 9.3B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while NIITLTD.NS trades at ₹68.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas NIITLTD.NS's P/E ratio is 40.84. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to NIITLTD.NS's ROE of +0.02%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to NIITLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check NIITLTD.NS's competition here
CLEDUCATE.NS vs NIITLTD.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, NIITLTD.BO has a market cap of 9.3B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while NIITLTD.BO trades at ₹68.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas NIITLTD.BO's P/E ratio is 40.84. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to NIITLTD.BO's ROE of +0.02%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to NIITLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check NIITLTD.BO's competition here
CLEDUCATE.NS vs GLOBAL.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, GLOBAL.NS has a market cap of 5.2B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while GLOBAL.NS trades at ₹102.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas GLOBAL.NS's P/E ratio is 23.24. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to GLOBAL.NS's ROE of +0.19%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to GLOBAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check GLOBAL.NS's competition here
CLEDUCATE.NS vs APTECHT.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, APTECHT.NS has a market cap of 5.1B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while APTECHT.NS trades at ₹88.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas APTECHT.NS's P/E ratio is 19.20. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to APTECHT.NS's ROE of +0.11%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to APTECHT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check APTECHT.NS's competition here
CLEDUCATE.NS vs APTECHT.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, APTECHT.BO has a market cap of 5.1B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while APTECHT.BO trades at ₹88.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas APTECHT.BO's P/E ratio is 19.18. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to APTECHT.BO's ROE of +0.11%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to APTECHT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check APTECHT.BO's competition here
CLEDUCATE.NS vs CLEDUCATE.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, CLEDUCATE.BO has a market cap of 2.9B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while CLEDUCATE.BO trades at ₹53.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas CLEDUCATE.BO's P/E ratio is -13.07. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to CLEDUCATE.BO's ROE of -0.12%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to CLEDUCATE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check CLEDUCATE.BO's competition here
CLEDUCATE.NS vs GOLDENCREST.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, GOLDENCREST.BO has a market cap of 1.7B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while GOLDENCREST.BO trades at ₹333.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas GOLDENCREST.BO's P/E ratio is 2564.23. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to GOLDENCREST.BO's ROE of +0.01%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to GOLDENCREST.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check GOLDENCREST.BO's competition here
CLEDUCATE.NS vs ZEELEARN.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, ZEELEARN.BO has a market cap of 1.6B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while ZEELEARN.BO trades at ₹4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas ZEELEARN.BO's P/E ratio is 15.84. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to ZEELEARN.BO's ROE of +0.05%. Regarding short-term risk, CLEDUCATE.NS is less volatile compared to ZEELEARN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check ZEELEARN.BO's competition here
CLEDUCATE.NS vs ZEELEARN.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, ZEELEARN.NS has a market cap of 1.6B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while ZEELEARN.NS trades at ₹4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas ZEELEARN.NS's P/E ratio is 15.81. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to ZEELEARN.NS's ROE of +0.05%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to ZEELEARN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check ZEELEARN.NS's competition here
CLEDUCATE.NS vs COMPUSOFT.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, COMPUSOFT.BO has a market cap of 1.1B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while COMPUSOFT.BO trades at ₹14.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas COMPUSOFT.BO's P/E ratio is 40.06. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to COMPUSOFT.BO's ROE of +0.02%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to COMPUSOFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check COMPUSOFT.BO's competition here
CLEDUCATE.NS vs COMPUSOFT.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, COMPUSOFT.NS has a market cap of 1.1B. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while COMPUSOFT.NS trades at ₹13.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas COMPUSOFT.NS's P/E ratio is 40.79. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to COMPUSOFT.NS's ROE of +0.02%. Regarding short-term risk, CLEDUCATE.NS is less volatile compared to COMPUSOFT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check COMPUSOFT.NS's competition here
CLEDUCATE.NS vs KEERTI.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, KEERTI.NS has a market cap of 733.1M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while KEERTI.NS trades at ₹71.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas KEERTI.NS's P/E ratio is 55.35. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to KEERTI.NS's ROE of +0.29%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to KEERTI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check KEERTI.NS's competition here
CLEDUCATE.NS vs LCCINFOTEC.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, LCCINFOTEC.BO has a market cap of 634.2M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while LCCINFOTEC.BO trades at ₹5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas LCCINFOTEC.BO's P/E ratio is -38.54. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to LCCINFOTEC.BO's ROE of -1.66%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to LCCINFOTEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check LCCINFOTEC.BO's competition here
CLEDUCATE.NS vs LCCINFOTEC.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, LCCINFOTEC.NS has a market cap of 630.4M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while LCCINFOTEC.NS trades at ₹4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas LCCINFOTEC.NS's P/E ratio is -55.33. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to LCCINFOTEC.NS's ROE of -1.66%. Regarding short-term risk, CLEDUCATE.NS is less volatile compared to LCCINFOTEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check LCCINFOTEC.NS's competition here
CLEDUCATE.NS vs TREEHOUSE.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, TREEHOUSE.BO has a market cap of 352M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while TREEHOUSE.BO trades at ₹8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas TREEHOUSE.BO's P/E ratio is -2.16. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to TREEHOUSE.BO's ROE of -0.08%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to TREEHOUSE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check TREEHOUSE.BO's competition here
CLEDUCATE.NS vs TREEHOUSE.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, TREEHOUSE.NS has a market cap of 350.3M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while TREEHOUSE.NS trades at ₹8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas TREEHOUSE.NS's P/E ratio is -2.15. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to TREEHOUSE.NS's ROE of -0.08%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to TREEHOUSE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check TREEHOUSE.NS's competition here
CLEDUCATE.NS vs KEEPLEARN.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, KEEPLEARN.BO has a market cap of 311.4M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while KEEPLEARN.BO trades at ₹2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas KEEPLEARN.BO's P/E ratio is -200.00. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to KEEPLEARN.BO's ROE of -0.03%. Regarding short-term risk, CLEDUCATE.NS is less volatile compared to KEEPLEARN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check KEEPLEARN.BO's competition here
CLEDUCATE.NS vs KEEPLEARN.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, KEEPLEARN.NS has a market cap of 309.9M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while KEEPLEARN.NS trades at ₹1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas KEEPLEARN.NS's P/E ratio is -199.00. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to KEEPLEARN.NS's ROE of -0.03%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to KEEPLEARN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check KEEPLEARN.NS's competition here
CLEDUCATE.NS vs GTECJAINX.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, GTECJAINX.NS has a market cap of 205.6M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while GTECJAINX.NS trades at ₹20.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas GTECJAINX.NS's P/E ratio is -22.67. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to GTECJAINX.NS's ROE of -2.61%. Regarding short-term risk, CLEDUCATE.NS is less volatile compared to GTECJAINX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check GTECJAINX.NS's competition here
CLEDUCATE.NS vs UMESLTD.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, UMESLTD.BO has a market cap of 173.6M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while UMESLTD.BO trades at ₹6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas UMESLTD.BO's P/E ratio is 50.54. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to UMESLTD.BO's ROE of +0.02%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to UMESLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check UMESLTD.BO's competition here
CLEDUCATE.NS vs UMESLTD.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, UMESLTD.NS has a market cap of 169.6M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while UMESLTD.NS trades at ₹6.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas UMESLTD.NS's P/E ratio is 49.38. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to UMESLTD.NS's ROE of +0.02%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to UMESLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check UMESLTD.NS's competition here
CLEDUCATE.NS vs EDUCOMP.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, EDUCOMP.NS has a market cap of 113.9M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while EDUCOMP.NS trades at ₹0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas EDUCOMP.NS's P/E ratio is -0.32. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to EDUCOMP.NS's ROE of +0.01%. Regarding short-term risk, CLEDUCATE.NS is less volatile compared to EDUCOMP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check EDUCOMP.NS's competition here
CLEDUCATE.NS vs EDUCOMP.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, EDUCOMP.BO has a market cap of 110.2M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while EDUCOMP.BO trades at ₹0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas EDUCOMP.BO's P/E ratio is -0.31. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to EDUCOMP.BO's ROE of +0.01%. Regarding short-term risk, CLEDUCATE.NS is less volatile compared to EDUCOMP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check EDUCOMP.BO's competition here
CLEDUCATE.NS vs MTEDUCARE.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, MTEDUCARE.NS has a market cap of 105.5M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while MTEDUCARE.NS trades at ₹1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas MTEDUCARE.NS's P/E ratio is -0.54. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to MTEDUCARE.NS's ROE of -9.24%. Regarding short-term risk, CLEDUCATE.NS is less volatile compared to MTEDUCARE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check MTEDUCARE.NS's competition here
CLEDUCATE.NS vs MTEDUCARE.BO Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, MTEDUCARE.BO has a market cap of 101.1M. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while MTEDUCARE.BO trades at ₹1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas MTEDUCARE.BO's P/E ratio is -0.52. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to MTEDUCARE.BO's ROE of -9.24%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to MTEDUCARE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check MTEDUCARE.BO's competition here
CLEDUCATE.NS vs DALALSTCOM.NS Comparison April 2026
CLEDUCATE.NS plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CLEDUCATE.NS stands at 2.9B. In comparison, DALALSTCOM.NS has a market cap of 0. Regarding current trading prices, CLEDUCATE.NS is priced at ₹52.87, while DALALSTCOM.NS trades at ₹1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CLEDUCATE.NS currently has a P/E ratio of -12.93, whereas DALALSTCOM.NS's P/E ratio is -3.06. In terms of profitability, CLEDUCATE.NS's ROE is -0.12%, compared to DALALSTCOM.NS's ROE of +529.59%. Regarding short-term risk, CLEDUCATE.NS is more volatile compared to DALALSTCOM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for CLEDUCATE.NS.Check DALALSTCOM.NS's competition here